VentriPoint Diagnostics (TSE:VPT) has released an update.
VentriPoint Diagnostics Ltd. has successfully completed the initial portion of a non-brokered private placement, raising $941,000 through the issuance of convertible debentures. These debentures are set to mature in 2027 and offer a 10% annual interest rate, with a conversion option into common shares at $0.25 each. The conversion could be automatic if share prices on the TSX Venture Exchange reach certain thresholds before October 2026, with additional incentives provided in the form of warrants.
For further insights into TSE:VPT stock, check out TipRanks’ Stock Analysis page.
